BamSEC and AlphaSense Join Forces
Learn More

Kura Oncology Inc. – Material Contracts

NASDAQ: KURA    
Share price (5/22/26): $11.25    
Market cap (5/22/26): $999 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.11
from 10-K 3 pages Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.4
from 10-Q 31 pages Co-Promotion and Medical Affairs Agreement
12/34/56
EX-10.2
from 10-Q 9 pages First Amendment to Lease
12/34/56
EX-10.1
from 10-Q 3 pages First Amendment to Lease
12/34/56
EX-10.36
from 10-K 91 pages Directors Science Park Lease
12/34/56
EX-10.35
from 10-K 10 pages Kura Oncology, Inc. Third Amended & Restated Executive Employment Agreement for Francis Burrows
12/34/56
EX-10.34
from 10-K 11 pages Kura Oncology, Inc. Third Amended & Restated Executive Employment Agreement for Mollie Leoni
12/34/56
EX-10.33
from 10-K 14 pages Without Prejudice and Subject to Contract Settlement Agreement This Agreement Is Made on January 1, 2025
12/34/56
EX-10.32
from 10-K 133 pages Collaboration and License Agreement
12/34/56
EX-10.15
from 10-K 3 pages Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 10-Q 4 pages Kura Oncology, Inc. Second Amendment to Amended and Restated Executive Employment Agreement
12/34/56
EX-10.2
from 8-K 28 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 50 pages Securities Purchase Agreement
12/34/56
EX-10.4
from 10-Q 40 pages Kura Oncology, Inc. $150,000,000 Common Stock Sales Agreement
12/34/56
EX-10.2
from 10-Q 11 pages This First Amendment to Lease (This “Amendment”), Is Made as of the 30th Day of August, 2023, by and Between East Office Operating Limited Partnership, a Massachusetts Limited Partnership, With an Address C/O Pembroke Real Estate LLC, 255 State Street, Boston, Massachusetts 02109 (The “Landlord”) and Kura Oncology, Inc, a Delaware Corporation, With an Address of 12730 High Bluff Drive, Suite 400, San Diego, California 92130 (The “Tenant”)
12/34/56
EX-10.1
from 10-Q 11 pages Executive Employment Agreement for Brian Powl
12/34/56
EX-10.2
from 10-Q 22 pages Stock Option Grant Notice - International
12/34/56
EX-10.1
from 10-Q 3 pages Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10
from 10-Q 15 pages Re: Transition and Separation Agreement Dear Kirsten: Kura Oncology, Inc. (The “Company”) Has Accepted Your Notice of Resignation to Pursue Other Opportunities. This Letter Sets Forth the Terms of the Separation Agreement (The “Agreement”) That the Company Is Offering to You to Aid in Your Employment Transition. 1
12/34/56
EX-10
from 10-K 7 pages Kura Oncology, Inc. Rsu Award Grant Notice
12/34/56